BSE Live
Jan 23, 16:01Prev. Close
68.50
Open Price
68.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:42Prev. Close
68.45
Open Price
68.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
66.40 (40)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -9.10 | 1.52 | 0.27 | -0.52 | 1.09 | |
| Diluted EPS (Rs.) | -9.10 | 1.52 | 0.27 | -0.52 | 1.09 | |
| Cash EPS (Rs.) | -3.68 | 5.86 | 5.04 | 4.30 | 5.65 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 31.99 | 42.49 | 42.48 | 42.38 | 42.51 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 31.99 | 42.49 | 42.48 | 42.38 | 42.51 | |
| Revenue from Operations/Share (Rs.) | 120.72 | 158.77 | 149.22 | 161.52 | 154.06 | |
| PBDIT/Share (Rs.) | 4.66 | 13.06 | 13.26 | 12.60 | 12.54 | |
| PBIT/Share (Rs.) | -0.76 | 8.72 | 8.48 | 8.02 | 7.09 | |
| PBT/Share (Rs.) | -9.55 | -0.14 | 2.03 | 2.03 | 2.06 | |
| Net Profit/Share (Rs.) | -9.10 | 1.52 | 0.27 | -0.28 | 0.20 | |
| NP After MI And SOA / Share (Rs.) | -8.62 | 2.67 | 1.96 | 1.24 | 1.09 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 3.85 | 8.22 | 8.88 | 7.79 | 8.13 | |
| PBIT Margin (%) | -0.62 | 5.49 | 5.68 | 4.96 | 4.60 | |
| PBT Margin (%) | -7.90 | -0.08 | 1.36 | 1.25 | 1.33 | |
| Net Profit Margin (%) | -7.53 | 0.95 | 0.17 | -0.17 | 0.13 | |
| NP After MI And SOA Margin (%) | -7.14 | 1.68 | 1.31 | 0.76 | 0.70 | |
| Return on Networth/Equity (%) | -23.30 | 5.68 | 4.28 | 2.81 | 2.55 | |
| Return on Capital Employed (%) | -1.36 | 12.60 | 11.36 | 12.61 | 1.40 | |
| Return on Assets (%) | -5.12 | 1.44 | 1.06 | 0.75 | 0.66 | |
| Total Debt/Equity (X) | 2.15 | 1.74 | 1.58 | 1.42 | 1.55 | |
| Asset Turnover Ratio (%) | 71.76 | 86.10 | 81.28 | 98.10 | 93.97 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.01 | 1.11 | 1.20 | 1.15 | 1.29 | |
| Quick Ratio (X) | 0.59 | 0.69 | 0.77 | 0.77 | 0.91 | |
| Inventory Turnover Ratio (X) | 2.53 | 3.23 | 3.18 | 4.18 | 4.75 | |
| Dividend Payout Ratio (NP) (%) | -11.59 | 0.00 | 0.00 | 97.06 | 100.84 | |
| Dividend Payout Ratio (CP) (%) | -31.21 | 0.00 | 0.00 | 20.68 | 16.84 | |
| Earnings Retention Ratio (%) | 111.59 | 0.00 | 0.00 | 2.94 | -0.84 | |
| Cash Earnings Retention Ratio (%) | 131.21 | 0.00 | 0.00 | 79.32 | 83.16 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | -0.09 | 0.98 | 1.32 | 1.34 | 1.41 | |
| Interest Coverage Ratios (Post Tax) (%) | -0.09 | 0.98 | 1.32 | 1.34 | 1.41 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 148.68 | 205.00 | 203.45 | 207.00 | 210.31 | |
| EV/Net Operating Revenue (X) | 0.87 | 0.91 | 0.96 | 0.90 | 1.06 | |
| EV/EBITDA (X) | 22.53 | 11.07 | 10.83 | 11.59 | 13.03 | |
| MarketCap/Net Operating Revenue (X) | 0.27 | 0.44 | 0.52 | 0.55 | 0.66 | |
| Retention Ratios (%) | 111.59 | 0.00 | 0.00 | 2.93 | -0.84 | |
| Price/BV (X) | 0.88 | 1.50 | 1.68 | 2.01 | 2.37 | |
| Price/Net Operating Revenue | 0.27 | 0.44 | 0.52 | 0.55 | 0.66 | |
| Earnings Yield | -0.26 | 0.04 | 0.03 | 0.01 | 0.01 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y